down arrow

Lincoln Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
552.90
14.65 (2.72%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Lincoln Pharmaceuticals Ltd stock-summary
stock-summary
Lincoln Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
Company Coordinates stock-summary
Company Details
Lincoln House B/H Satyam Compe, Science City Road Sola Ahmedabad Gujarat : 380060
stock-summary
Tel: 91-079-67778000
stock-summary
info@lincolnpharma.com
Registrar Details
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 20.03 Cr
Number of Shares
2 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Oct-2021
2
20.03
29728
10
Scheme of Amalgamation
27-Oct-2016
2
20.00
3689200
10
Conversion of Warrants
27-Oct-2016
2
20.00
3689200
10
Conversion of Warrants
15-Oct-2010
1.63
16.31
5000000
10
Allotment of Equity To Others
15-Oct-2010
1.63
16.31
5000000
10
Allotment of Equity To Others
20-Jan-2010
1.13
11.31
1300000
10
Conversion of Warrants
20-Jan-2010
1.13
11.31
1300000
10
Conversion of Warrants
15-Oct-2009
1
10.01
2400000
10
Allotment of Equity Shares To Promoter & Others
15-Oct-2009
1
10.01
2400000
10
Allotment of Equity Shares To Promoter & Others
19-Mar-2009
76.11
7.61
-30443200
10
Consolidation of Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 44 FIIs (5.16%)

Promoter with highest holding

Munjal Mahendrabhai Patel (13.37%)

Highest Public shareholder

Kishor M. Shah (2.39%)

Individual Investors Holdings

36.71%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Kishorbhai M Shah
Chairman (Non-Executive)
0
Mahendra G Patel
Managing Director
27.75 lacs
Hasmukhbhai I Patel
Whole-time Director
33.25 lacs
Pirabhai R Suthar
Independent Director
0
Munjal Mahendrabhai Patel
Whole-time Director
30.39 lacs
Aashish R Patel
Whole-time Director
47.17 lacs
Meha Patel
Independent Director
0
Saurin J Parikh
Independent Director
0
Rajnikant G Patel
Director
0
Anand Arvindbhai Patel
Whole-time Director
0
Trusha Shah
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of finished goods
88.91009
0%
 
100
Purchase of finished goods
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Goods
317.49
97.53%
Export Incentives
5.51
1.69%
Jobwork Charges
2.41
0.74%
 
97.53
Pharmaceutical Goods
2.47
Pharmaceutical Goods
1.69
Export Incentives
98.31
Export Incentives
0.74
Jobwork Charges
99.26
Jobwork Charges
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
147 Cr
(Quarterly Results - Dec 2024)
Net Profit:
21 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,107 Cr (Small Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

15.12%

stock-summary
Price to Book

1.69